Ubiquitin-specific protease 14 regulates cardiac hypertrophy progression by increasing GSK-3β phosphorylation

Biochemical and Biophysical Research Communications

Volumn 478, Issue 3, 2016, Pages 1236-1241

  Liu, Ningning ^a   Chai, Renjie ^a   Liu, Bin ^a   Zhang, Zhenhui ^a   Zhang, Shuangwei ^a   Zhang, Jingzhi ^a   Liao, Yuning ^a   Cai, Jianyu ^a   Xia, Xiaohong ^a   Li, Aiqun ^a   Liu, Jinbao ^a   Huang, Hongbiao ^a   Liu, Shiming ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac hypertrophy; Deubiquitinase; GSK 3 ; USP14

Indexed keywords

ANGIOTENSIN II; DEUBIQUITINASE; GLYCOGEN SYNTHASE KINASE 3BETA; BIOLOGICAL MARKER; MYOSIN HEAVY CHAIN; UBIQUITIN THIOLESTERASE; USP14 PROTEIN, RAT;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME INHIBITION; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; CARDIAC MUSCLE; CARDIOMEGALY; DIAGNOSTIC IMAGING; DISEASE MODEL; ENZYMOLOGY; GENE SILENCING; HEART VENTRICLE; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; STENOSIS, OCCLUSION AND OBSTRUCTION;

ANIMALS; ANIMALS, NEWBORN; AORTA, ABDOMINAL; BIOMARKERS; CARDIOMEGALY; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE KNOCKDOWN TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3 BETA; HEART VENTRICLES; MALE; MYOCARDIUM; MYOSIN HEAVY CHAINS; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; UBIQUITIN THIOLESTERASE;

EID: 84994035364     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.08.100     Document Type: Article

References (20)

1. [1] Hunter, J.J., Chien, K.R., Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341 (1999), 1276–1283.
2. [2] Weber, K.T., Janicki, J.S., Shroff, S.G., Pick, R., Chen, R.M., Bashey, R.I., Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ. Res. 62 (1988), 757–765.
3. [3] Ciechanover, A., The ubiquitin-proteasome proteolytic pathway. Cell 79 (1994), 13–21.
4. [4] Balasubramanian, S., Mani, S., Shiraishi, H., Johnston, R.K., Yamane, K., Willey, C.D., Cooper, G.t., Tuxworth, W.J., Kuppuswamy, D., Enhanced ubiquitination of cytoskeletal proteins in pressure overloaded myocardium is accompanied by changes in specific E3 ligases. J. Mol. Cell. Cardiol. 41 (2006), 669–679.
5. [5] Depre, C., Wang, Q., Yan, L., Hedhli, N., Peter, P., Chen, L., Hong, C., Hittinger, L., Ghaleh, B., Sadoshima, J., Vatner, D.E., Vatner, S.F., Madura, K., Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation 114 (2006), 1821–1828.
6. [6] Liu, S., Zhao, C., Yang, C., Li, X., Huang, H., Liu, N., Li, S., Wang, X., Liu, J., Gambogic acid suppresses pressure overload cardiac hypertrophy in rats. Am. J. Cardiovasc Dis. 3 (2013), 227–238.
7. [7] Zhao, C., Liu, S., Yang, C., Li, X., Huang, H., Liu, N., Li, S., Wang, X., Liu, J., Gambogic acid moderates cardiac responses to chronic hypoxia likely by acting on the proteasome and NF-kappaB pathway. Am. J. Cardiovasc Dis. 3 (2013), 135–145.
8. [8] D'Arcy, P., Brnjic, S., Olofsson, M.H., Fryknas, M., Lindsten, K., De Cesare, M., Perego, P., Sadeghi, B., Hassan, M., Larsson, R., Linder, S., Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat. Med. 17 (2011), 1636–1640.
9. [9] Tian, Z., D'Arcy, P., Wang, X., Ray, A., Tai, Y.T., Hu, Y., Carrasco, R.D., Richardson, P., Linder, S., Chauhan, D., Anderson, K.C., A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance. Blood 123 (2014), 706–716.
10. [10] Wu, N., Liu, C., Bai, C., Han, Y.P., Cho, W.C., Li, Q., Over-expression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of beta-catenin. Int. J. Mol. Sci. 14 (2013), 10749–10760.
11. [11] Shinji, S., Naito, Z., Ishiwata, S., Ishiwata, T., Tanaka, N., Furukawa, K., Suzuki, H., Seya, T., Matsuda, A., Katsuta, M., Tajiri, T., Ubiquitin-specific protease 14 expression in colorectal cancer is associated with liver and lymph node metastases. Oncol. Rep. 15 (2006), 539–543.
12. [12] Antos, C.L., McKinsey, T.A., Frey, N., Kutschke, W., McAnally, J., Shelton, J.M., Richardson, J.A., Hill, J.A., Olson, E.N., Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 907–912.
13. [13] Hardt, S.E., Sadoshima, J., Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ. Res. 90 (2002), 1055–1063.
14. [14] Chen, B., Ma, Y., Meng, R., Xiong, Z., Zhang, C., Chen, G., Zhang, A., Dong, Y., MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals. Acta Biochim. Biophys. Sin. (Shanghai) 42 (2010), 253–258.
15. [15] Glickman, M.H., Ciechanover, A., The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2002), 373–428.
16. [16] Hammond-Martel, I., Yu, H., Affar el, B., Roles of ubiquitin signaling in transcription regulation. Cell Signal 24 (2012), 410–421.
17. [17] Hochstrasser, M., Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol. 7 (1995), 215–223.
18. [18] Cook, S.A., Novikov, M.S., Ahn, Y., Matsui, T., Rosenzweig, A., A20 is dynamically regulated in the heart and inhibits the hypertrophic response. Circulation 108 (2003), 664–667.
19. [19] Huang, H., Tang, Q.Z., Wang, A.B., Chen, M., Yan, L., Liu, C., Jiang, H., Yang, Q., Bian, Z.Y., Bai, X., Zhu, L.H., Wang, L., Li, H., Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling. Hypertension 56 (2010), 232–239.
20. [20] Wang, H., Lai, Y., Mathis, B.J., Wang, W., Li, S., Qu, C., Li, B., Shao, L., Song, H., Janicki, J.S., Sun, S.C., Wang, X.L., Tang, D., Cui, T., Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2. J. Mol. Cell. Cardiol. 84 (2015), 143–153.